Evogene (EVGN) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Evogene Ltd. reported a 35% increase in total revenues for the first nine months of 2024, driven by Casterra’s seed sales, despite a drop in Q3 revenue compared to last year. The company has strengthened its cash position by reducing expenses and completed a $5.5 million fundraising. Evogene is enhancing its AI tech-engines through collaboration with Google Cloud to expand its market potential in life-science product development.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
